The global Targeted DNA & RNA Sequencing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Targeted RNA-sequencing (RNA-Seq) is听a highly accurate method for selecting and sequencing specific transcripts of interest. It offers both quantitative and qualitative information.
This report includes an overview of the development of the Targeted DNA & RNA Sequencing industry chain, the market status of Human Biomedical Research (DNA-based Targeted Sequencing, RNA-based Targeted Sequencing), Plant & Animal Sciences (DNA-based Targeted Sequencing, RNA-based Targeted Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted DNA & RNA Sequencing.
Regionally, the report analyzes the Targeted DNA & RNA Sequencing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted DNA & RNA Sequencing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted DNA & RNA Sequencing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted DNA & RNA Sequencing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., DNA-based Targeted Sequencing, RNA-based Targeted Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted DNA & RNA Sequencing market.
Regional Analysis: The report involves examining the Targeted DNA & RNA Sequencing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted DNA & RNA Sequencing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted DNA & RNA Sequencing:
Company Analysis: Report covers individual Targeted DNA & RNA Sequencing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted DNA & RNA Sequencing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Human Biomedical Research, Plant & Animal Sciences).
Technology Analysis: Report covers specific technologies relevant to Targeted DNA & RNA Sequencing. It assesses the current state, advancements, and potential future developments in Targeted DNA & RNA Sequencing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted DNA & RNA Sequencing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeted DNA & RNA Sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Market segment by Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
Market segment by players, this report covers
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted DNA & RNA Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted DNA & RNA Sequencing, with revenue, gross margin and global market share of Targeted DNA & RNA Sequencing from 2019 to 2024.
Chapter 3, the Targeted DNA & RNA Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Targeted DNA & RNA Sequencing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted DNA & RNA Sequencing.
Chapter 13, to describe Targeted DNA & RNA Sequencing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Targeted DNA & RNA Sequencing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Targeted DNA & RNA Sequencing by Type
1.3.1 Overview: Global Targeted DNA & RNA Sequencing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Targeted DNA & RNA Sequencing Consumption Value Market Share by Type in 2023
1.3.3 DNA-based Targeted Sequencing
1.3.4 RNA-based Targeted Sequencing
1.4 Global Targeted DNA & RNA Sequencing Market by Application
1.4.1 Overview: Global Targeted DNA & RNA Sequencing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Human Biomedical Research
1.4.3 Plant & Animal Sciences
1.4.4 Drug Discovery
1.4.5 Others
1.5 Global Targeted DNA & RNA Sequencing Market Size & Forecast
1.6 Global Targeted DNA & RNA Sequencing Market Size and Forecast by Region
1.6.1 Global Targeted DNA & RNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Targeted DNA & RNA Sequencing Market Size by Region, (2019-2030)
1.6.3 North America Targeted DNA & RNA Sequencing Market Size and Prospect (2019-2030)
1.6.4 Europe Targeted DNA & RNA Sequencing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Targeted DNA & RNA Sequencing Market Size and Prospect (2019-2030)
1.6.6 South America Targeted DNA & RNA Sequencing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Targeted DNA & RNA Sequencing Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Illumina, Inc.
2.1.1 Illumina, Inc. Details
2.1.2 Illumina, Inc. Major Business
2.1.3 Illumina, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.1.4 Illumina, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Illumina, Inc. Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche Ltd
2.2.1 F. Hoffmann-La Roche Ltd Details
2.2.2 F. Hoffmann-La Roche Ltd Major Business
2.2.3 F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Product and Solutions
2.2.4 F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.3 Agilent Technologies
2.3.1 Agilent Technologies Details
2.3.2 Agilent Technologies Major Business
2.3.3 Agilent Technologies Targeted DNA & RNA Sequencing Product and Solutions
2.3.4 Agilent Technologies Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Agilent Technologies Recent Developments and Future Plans
2.4 GATC Biotech Ag
2.4.1 GATC Biotech Ag Details
2.4.2 GATC Biotech Ag Major Business
2.4.3 GATC Biotech Ag Targeted DNA & RNA Sequencing Product and Solutions
2.4.4 GATC Biotech Ag Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GATC Biotech Ag Recent Developments and Future Plans
2.5 Oxford Nanopore Technologies
2.5.1 Oxford Nanopore Technologies Details
2.5.2 Oxford Nanopore Technologies Major Business
2.5.3 Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Product and Solutions
2.5.4 Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.6 Thermo Fisher Scientific, Inc.
2.6.1 Thermo Fisher Scientific, Inc. Details
2.6.2 Thermo Fisher Scientific, Inc. Major Business
2.6.3 Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.6.4 Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.7 DNASTAR Inc.
2.7.1 DNASTAR Inc. Details
2.7.2 DNASTAR Inc. Major Business
2.7.3 DNASTAR Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.7.4 DNASTAR Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 DNASTAR Inc. Recent Developments and Future Plans
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business
2.8.3 QIAGEN Targeted DNA & RNA Sequencing Product and Solutions
2.8.4 QIAGEN Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 QIAGEN Recent Developments and Future Plans
2.9 BGI
2.9.1 BGI Details
2.9.2 BGI Major Business
2.9.3 BGI Targeted DNA & RNA Sequencing Product and Solutions
2.9.4 BGI Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 BGI Recent Developments and Future Plans
2.10 Perkin Elmer, Inc.
2.10.1 Perkin Elmer, Inc. Details
2.10.2 Perkin Elmer, Inc. Major Business
2.10.3 Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.10.4 Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Perkin Elmer, Inc. Recent Developments and Future Plans
2.11 Pacific Biosciences of California, Inc.
2.11.1 Pacific Biosciences of California, Inc. Details
2.11.2 Pacific Biosciences of California, Inc. Major Business
2.11.3 Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.11.4 Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Pacific Biosciences of California, Inc. Recent Developments and Future Plans
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Bio-Rad Laboratories, Inc. Details
2.12.2 Bio-Rad Laboratories, Inc. Major Business
2.12.3 Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.12.4 Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.13 Integrated DNA Technologies, Inc.
2.13.1 Integrated DNA Technologies, Inc. Details
2.13.2 Integrated DNA Technologies, Inc. Major Business
2.13.3 Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.13.4 Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Integrated DNA Technologies, Inc. Recent Developments and Future Plans
2.14 RainDance Technologies, Inc.
2.14.1 RainDance Technologies, Inc. Details
2.14.2 RainDance Technologies, Inc. Major Business
2.14.3 RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.14.4 RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 RainDance Technologies, Inc. Recent Developments and Future Plans
2.15 PierianDx
2.15.1 PierianDx Details
2.15.2 PierianDx Major Business
2.15.3 PierianDx Targeted DNA & RNA Sequencing Product and Solutions
2.15.4 PierianDx Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 PierianDx Recent Developments and Future Plans
2.16 Genomatix GmbH
2.16.1 Genomatix GmbH Details
2.16.2 Genomatix GmbH Major Business
2.16.3 Genomatix GmbH Targeted DNA & RNA Sequencing Product and Solutions
2.16.4 Genomatix GmbH Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Genomatix GmbH Recent Developments and Future Plans
2.17 Macrogen, Inc.
2.17.1 Macrogen, Inc. Details
2.17.2 Macrogen, Inc. Major Business
2.17.3 Macrogen, Inc. Targeted DNA & RNA Sequencing Product and Solutions
2.17.4 Macrogen, Inc. Targeted DNA & RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Macrogen, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted DNA & RNA Sequencing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Targeted DNA & RNA Sequencing by Company Revenue
3.2.2 Top 3 Targeted DNA & RNA Sequencing Players Market Share in 2023
3.2.3 Top 6 Targeted DNA & RNA Sequencing Players Market Share in 2023
3.3 Targeted DNA & RNA Sequencing Market: Overall Company Footprint Analysis
3.3.1 Targeted DNA & RNA Sequencing Market: Region Footprint
3.3.2 Targeted DNA & RNA Sequencing Market: Company Product Type Footprint
3.3.3 Targeted DNA & RNA Sequencing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Targeted DNA & RNA Sequencing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Targeted DNA & RNA Sequencing Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Targeted DNA & RNA Sequencing Consumption Value Market Share by Application (2019-2024)
5.2 Global Targeted DNA & RNA Sequencing Market Forecast by Application (2025-2030)
6 North America
6.1 North America Targeted DNA & RNA Sequencing Consumption Value by Type (2019-2030)
6.2 North America Targeted DNA & RNA Sequencing Consumption Value by Application (2019-2030)
6.3 North America Targeted DNA & RNA Sequencing Market Size by Country
6.3.1 North America Targeted DNA & RNA Sequencing Consumption Value by Country (2019-2030)
6.3.2 United States Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
6.3.3 Canada Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
6.3.4 Mexico Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Targeted DNA & RNA Sequencing Consumption Value by Type (2019-2030)
7.2 Europe Targeted DNA & RNA Sequencing Consumption Value by Application (2019-2030)
7.3 Europe Targeted DNA & RNA Sequencing Market Size by Country
7.3.1 Europe Targeted DNA & RNA Sequencing Consumption Value by Country (2019-2030)
7.3.2 Germany Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
7.3.3 France Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
7.3.5 Russia Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
7.3.6 Italy Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Targeted DNA & RNA Sequencing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Targeted DNA & RNA Sequencing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Targeted DNA & RNA Sequencing Market Size by Region
8.3.1 Asia-Pacific Targeted DNA & RNA Sequencing Consumption Value by Region (2019-2030)
8.3.2 China Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
8.3.3 Japan Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
8.3.4 South Korea Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
8.3.5 India Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
8.3.7 Australia Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
9 South America
9.1 South America Targeted DNA & RNA Sequencing Consumption Value by Type (2019-2030)
9.2 South America Targeted DNA & RNA Sequencing Consumption Value by Application (2019-2030)
9.3 South America Targeted DNA & RNA Sequencing Market Size by Country
9.3.1 South America Targeted DNA & RNA Sequencing Consumption Value by Country (2019-2030)
9.3.2 Brazil Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
9.3.3 Argentina Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Targeted DNA & RNA Sequencing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Targeted DNA & RNA Sequencing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Targeted DNA & RNA Sequencing Market Size by Country
10.3.1 Middle East & Africa Targeted DNA & RNA Sequencing Consumption Value by Country (2019-2030)
10.3.2 Turkey Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
10.3.4 UAE Targeted DNA & RNA Sequencing Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Targeted DNA & RNA Sequencing Market Drivers
11.2 Targeted DNA & RNA Sequencing Market Restraints
11.3 Targeted DNA & RNA Sequencing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Targeted DNA & RNA Sequencing Industry Chain
12.2 Targeted DNA & RNA Sequencing Upstream Analysis
12.3 Targeted DNA & RNA Sequencing Midstream Analysis
12.4 Targeted DNA & RNA Sequencing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.
听
听
*If Applicable.
